2528results about How to "Stay flexible" patented technology

Medical devices, and in particular implantable medical devices, including self-expanding stents, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The devices utilized to deliver the implantable medical devices may be modified to reduce the potential for damaging the implantable medical device during deployment.

A high level transformation method and apparatus for converting data formats in the context of network applications, among other places. A flexible transformation mechanism is provided that facilitates generation of translation machine code. A translator is dynamically generated by a translator compiler engine. When fed an input stream, the translator generates an output stream by executing the native object code generated on the fly by the translator compiler engine. In addition, the translator may be configured to perform a bi-directional translation between the two streams as well as translation between two distinct protocol sequences. Further a translator may working in streaming mode, to facilitate streaming processing of documents.

A modular power transmitting system comprises multiple transmitter modules being connected together for transmitting power inductively to a receiver. The transmitter module is connected with other transmitter modules for transmitting power inductively to the receiver, wherein the transmitter module (40) comprises at least one transmitter cell (30), each transmitter cell having one transmitter coil (33) by which the transmitter cell transmitting power to the receiver, the transmitter module having an outer periphery (45) being shaped so as to fit to neighboring transmitter modules for forming an power transmitting surface, the at least one transmitter cell being arranged such that the power transmitting surface is constituted by an uninterrupted pattern of adjacent transmitter coils extending in said surface, and interconnection units (110,111) for connecting with neighboring transmitter modules for sharing a power supply.

This invention describes a new methodology for a cell reselection by a mobile station (MS) for improving network interconnection and interoperability in a limited mobile access environment. The invention is applicable to any kind of networks and their interconnections. The invention describes how the MS can better recover from failed intersystem cell reselection attempts so that there are fewer subsequent failed attempts using two major improvements. First, the MS takes into consideration during cell reselection evaluation and candidate-cell selection, whether the MS had previously been unsuccessful in reselecting the considered cell. This means treating neighbor cells to which the MS had failed reselection before with a lower priority in subsequent cell reselection evaluations. Second, the MS is allowed to stop monitoring and thus, to stop evaluating cells if it was earlier found that the access to those cells is forbidden.

An orthopedic implantable device articulately connecting a first spinal vertebra to an adjacent second spinal vertebra includes a pair of first components adapted to be attached to locations left and right of a midline of the first vertebra, respectively; and a pair of second components adapted to be attached to locations left and right of a midline of the second vertebra, respectively. Each of the first components includes a body and a male articulation member attached to the first component body and each of the second components includes a body and a female articulation member attached to the second component body. The first components are articulately connected to the second components by engaging the male articulation members to the female articulation members, thereby articulately connecting the first vertebra to said second vertebra along lines left and right of the midlines, respectively.

A shield that is attachable to a touch sensitive screen is disclosed. The shield may be attached to the touch sensitive screen only at its outer peripheral portion. An air gap is enclosed between the shield and the touch sensitive screen to form a planar air bearing. The shield preferably does not touch the active area of the touch sensitive screen when the user is not touching the shield but only viewing the touch sensitive screen through the shield. This mitigates unwanted optical artifacts such as trapped air bubbles, Newton rings and chromatic interference while maintaining the sensitivity of the touch sensitive screen.

An LED array surface-mounted on a circuit board and applied to a cooling member, such that any generated heat is optimally eliminated. The cooling member can be in any desired shape so that motor vehicle lights, such as blinkers, can be adapted to the outside contour of the vehicle. For a rotating light, the circuit board can be applied around a cooling member fashioned as a hollow cylindrical member which is adapted to rotate.

An intracardiac device for restoring the functional elasticity of the cardiac structures, in particular for the treatment of cardiomyopathies and or valvulopathies, by storing energy from the cardiac structures and ceding energy to the cardiac structures during the cardiac cycle, has an elongated shape, is at least partially wound in coils and is attachable to a cardiac structure; the coils are selected in material, number and dimension so as to allow an elastic elongation of the intracardiac device higher than 10% of the rest length of the intracardiac device and are exposed, in use, to the blood flow.

A computer system including a plurality of physical processors (CPs) having physical processor performances (PCPs), a plurality of logical processors (LCPs), a plurality of logical partitions (LPARs) where each partition includes one or more of the logical processors (LCPs), and a system assist processor having a control element. The control element controls the virtualization of the physical processors (CPs), the logical partitions (LPARs) and the logical processors (LCPs) and allocates the physical processor performances (PCPs) to the logical partitions (LPARs). The control element operates to exclusively bind logical processors (LCPs) to the physical processors (CPs). For a logical processor (LCP) exclusively bound to a physical processor (CP), the logical processor (LCP) has exclusive use of the underlying physical processor (CP) and no other logical processor (LCP) can be dispatched on the underlying physical processor (CP) even if the underlying physical processor (CP) is otherwise available.

Reusable vacuum bags are provided which include a fabric layer containing reinforcement fibers and a release surface disposed on at least the first side of the fabric layer. The vacuum bag is capable of withstanding multiple mold cycles of the vacuum of less than ambient pressure without significant leakage. In addition, the described vacuum bag can be used in resin transfer molding and standard bagging operations with commercial benefit.

A network switch, configured for performing layer 2 and layer 3 switching in an Ethernet (IEEE 802.3) network without blocking of incoming data packets, includes network switch ports, each including a flow module configured for generating a packet signature based on layer 3 information within a received data packet. The flow module generates first and second hash keys according to a prescribed hashing function upon obtaining first and second portions of layer 3 information. The flow module combines the first and second hash keys to form the packet signature, and searches an on-chip signature table that indexes addresses of layer 3 switching entries by entry signatures, where the entry signatures are generated using the same prescribed hashing function on the first and second layer 3 portions of the layer 3 switching entries.

Apparatus and methods for interlocking stent segments which provide for a secure engagement between the expanded stent segments are described herein. Stent segments which are able to slide freely relative to one another along the deployment catheter prior to expansion may be secured to one another when expanded and/or deployed into the vessel. Securement upon expansion of the stent segments may be accomplished, in part, by utilizing one or more coupling mechanisms between adjacent stent segments which securely interlock the segments to one another by taking advantage of the changing geometry of the stents during expansion.

A flexible covered stent having a stent covered on a first surface by a first layer of biocompatible material and on a second surface by both a second and third layer of biocompatible material, the first and second layers and the first and third layers of biocompatible material being bonded to one another through openings in a wall in the stent. The first layer of biocompatible material is longer than both the second and third layers of biocompatible material such that at least a portion of the second surface of the stent is not covered by either second or third layer, imparting flexibility to the stent.

A scanning architecture that makes it possible to update only those ultrasonic transducer subelements of a mosaic transducer array that change from view to view. The configuration of the switch matrix is fully programmable. The switch matrix includes access switches that connect subelements to bus lines and matrix switches that connect subelements to subelements. Each subelement has a unit switch cell associated therewith, each unit switch cell comprising at least one access switch, at least one matrix switch, and addressing and control logic. Optionally, each unit switch cell also includes latches for storing the future switch states of the switches to be programmed. The switches themselves have memory for storing their current switch states.

A stent formed of polymeric material, useful for the expansion of a lumen and the delivery of one or more therapeutic agents in situ is disclosed. The stent may be multi-layered, and may change shape at a state transition temperature governed by the materials forming the layers. Methods of use and manufacture are also disclosed.

Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. Therapeutic agents may also be delivered to the region of a disease site. In regional delivery, liquid formulations may be desirable to increase the efficacy and deliverability of the particular drug. Also, the devices may be modified to promote endothelialization. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned. In addition, the devices utilized to deliver the implantable medical devices may be modified to reduce the potential for damaging the implantable medical device during deployment. Medical devices include stents, grafts, anastomotic devices, perivascular wraps, sutures and staples. In addition, various polymer combinations may be utilized to control the elution rates of the therapeutic drugs, agents and/or compounds from the implantable medical devices.

A semiconductor device of the present invention includes a chip which has a pad; a bump electrode formed on the pad; and a wire whose stitch bonding is made on the bump electrode. The wire satisfies a condition: (modulus-of-elasticity/breaking strength per unit area) ≧400.

A shield that is attachable to a touch sensitive screen is disclosed. The shield may be attached to the touch sensitive screen only at its outer peripheral portion. An air gap is enclosed between the shield and the touch sensitive screen to form a planar air bearing. The shield preferably does not touch the active area of the touch sensitive screen when the user is not touching the shield but only viewing the touch sensitive screen through the shield. This mitigates unwanted optical artifacts such as trapped air bubbles, Newton rings and chromatic interference while maintaining the sensitivity of the touch sensitive screen.

Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. The drugs, agents, and/or compounds may also be utilized to treat specific diseases, including vulnerable plaque. Therapeutic agents may also be delivered to the region of a disease site. In regional delivery, liquid formulations may be desirable to increase the efficacy and deliverability of the particular drug. Also, the devices may be modified to promote endothelialization. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned. In addition, the devices utilized to deliver the implantable medical devices may be modified to reduce the potential for damaging the implantable medical device during deployment. Medical devices include stents, grafts, anastomotic devices, perivascular wraps, sutures and staples. In addition, various polymer combinations may be utilized to control the elution rates of the therapeutic drugs, agents and/or compounds from the implantable medical devices. Liquid formulations, including solutions and suspensions of the various drugs, agents and/or compounds, may be locally or regionally delivered. In each of these instances, antioxidants are utilized to prolong product integrity.